Telcatan 80 mg (Telmisartan)

Adult dose

1. Essential Hypertension As Telmisartan, 40 mg should be taken orally once daily with water, regardless of meals. In some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect typically occurs 4 - 8 weeks after dose increase. This medication may be used in combination with thiazide diuretics such as hydrochlorothiazide for additional effect.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with a known allergy to this medication, pregnant or breastfeeding women, patients with severe liver dysfunction or bile obstruction, hereditary angioedema patients, and patients with diabetes or severe kidney dysfunction should not take this medication. Elderly patients, those with hyperkalemia, liver disorders, heart valve diseases, ischemic heart disease, gastrointestinal disorders, renal artery hypertension, and severe kidney disorders should use this medication with caution. Various adverse reactions may occur while taking this medication, and patients should consult a healthcare professional immediately if they experience significantly low blood pressure, hyperkalemia, renal dysfunction, angioedema, liver abnormalities, interstitial lung disease, or rhabdomyolysis. Patients with impaired renal function should regularly check their serum potassium and creatinine levels, and correct their blood volume and sodium status in advance if they are at risk of hypotension. This medication can enhance the blood pressure-lowering effect when used with other antihypertensive agents, so caution is required. Particularly, the risk of side effects may increase when used concurrently with other RAAS agents, potassium-sparing diuretics, NSAIDs, lithium, etc., so it is advisable to consult a doctor. It should never be taken during pregnancy, and it is also recommended to avoid taking it while breastfeeding. Safety and efficacy have not been established in children under 18 years, so it is not recommended. In elderly patients, this medication must be administered with caution due to the risk of excessive blood pressure lowering leading to stroke. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may appear, requiring immediate medical treatment. This medication should be kept out of reach of children and stored sealed until the time of administration.

Serious side effects

Urticaria, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, sepsis, anaphylactic reactions, angioedema, severe allergic reactions, severe skin adverse effects, respiratory distress, hepatic dysfunction, liver damage, jaundice, sudden and severe headache, seizures, confusion, paralysis, neurological symptoms, significantly decreased urine output, severe swelling all over the body and increased blood pressure, acute renal failure, shock,

Mild side effects

• Upper respiratory tract infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius. This will help retain the medication's effectiveness and safety for an extended period.

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle